Odey Asset Management Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Odey Asset Management Group’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$4.1M	Buy	+170,019	New	+$2.13M	1.07%	12

Other funds holding PRVB

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Odey Asset Management Group's PRVB Position: Q1 2023 in Review

Odey Asset Management Group opened a new position in Provention Bio, Inc. Common Stock (PRVB) in Q1 2023: 170,019 shares worth $4.1M. The stake represents 1.07% of the portfolio and ranks #12 among its holdings.

182 funds tracked by Wall St. Rank hold PRVB as of Q1 2023.

Odey Asset Management Group held 170,019 shares of Provention Bio, Inc. Common Stock worth $4.1M as of Q1 2023.
Provention Bio, Inc. Common Stock was a new Odey Asset Management Group position in Q1 2023.
Provention Bio, Inc. Common Stock made up 1.07% of Odey Asset Management Group's portfolio in Q1 2023, its #12 holding.
182 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q1 2023.

Based on Odey Asset Management Group's 13F filing for Q1 2023, filed 15 May 2023.